ARTICLE | Clinical News
Cetrorelix: Phase III started
May 19, 2008 7:00 AM UTC
Aeterna Zentaris began an open-label, North American and European Phase III trial to evaluate intramuscular cetrorelix in 500 male patients. The product is marketed as Cetrotide for in vitro fertiliz...